OverviewChartProfileKey statisticsFinancialsTechnicalNewsTraderScreen

Agios Pharmaceuticals Inc/  US00847X1046  /

NASDAQ
2024-04-24  10:00:00 PM Chg. -0.1400 Volume Bid1:59:51 AM Ask1:59:51 AM High Low
31.6700USD -0.44% 643,302
Turnover: 12.34 mill.		 12.6700Bid Size: 200 33.1100Ask Size: 100 32.2600 31.3200
GlobeNewswire 04-18 Agios to Webcast Conference Call of First Quarter 2024 Financial Results on May 2, 2024
GlobeNewswire 04-09 Agios Publishes 2024 Environmental, Social and Governance (ESG) Report
GlobeNewswire 03-05 Agios to Present at the Leerink Partners Global Biopharma Conference on March 12, 2024
GlobeNewswire 02-22 Agios to Present at the TD Cowen 44th Annual Health Care Conference on March 4, 2024
GlobeNewswire 02-15 OnKure Announces the Appointment of Samuel Agresta, M.D., as Chief Medical Officer
GlobeNewswire 02-15 Agios Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights
GlobeNewswire 02-02 Agios to Webcast Conference Call of Fourth Quarter and Year End 2023 Financial Results on February 1...
GlobeNewswire 01-08 Agios Announces Key Anticipated 2024 Milestones Across Rare Disease Portfolio
GlobeNewswire 01-03 Agios Announces Phase 3 ENERGIZE Study of Mitapivat Met Primary Endpoint and Both Key Secondary Endp...
GlobeNewswire 01-02 Agios to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 10, 2024
GlobeNewswire 2023-12-10 Agios Presents Positive Results from Phase 2 Portion of the RISE UP Pivotal Study in Sickle Cell Dis...
GlobeNewswire 2023-11-20 Agios Announces Clinical Proof-of-Concept in Phase 2a Trial of AG-946 for the Treatment of Anemia in...
GlobeNewswire 2023-11-02 Agios Pharmaceuticals to Present Broad Set of Clinical and Translational Data in Rare Blood Disorder...
GlobeNewswire 2023-11-02 Agios Reports Business Highlights and Third Quarter 2023 Financial Results
GlobeNewswire 2023-10-19 Agios to Webcast Conference Call of Third Quarter 2023 Financial Results on Nov. 2, 2023
GlobeNewswire 2023-09-19 Marketing and Finance Leaders Seek Collaboration to Make Smarter Investments, Says CMO Council and K...
GlobeNewswire 2023-09-08 Regeneron Announces Updates to Board of Directors
GlobeNewswire 2023-09-05 C4 Therapeutics Announces Chief Financial Officer Succession
GlobeNewswire 2023-08-29 Agios to Present at the Morgan Stanley Global Healthcare Conference on September 12, 2023
GlobeNewswire 2022-03-07 ProQR Appoints John Maraganore, PhD, as Strategic Advisor to the Supervisory Board
GlobeNewswire 2022-02-28 Agios to Participate in March Investor Conferences
GlobeNewswire 2022-02-24 Agios Reports Fourth Quarter and Full Year 2021 Financial Results
GlobeNewswire 2022-02-17 Agios Announces FDA Approval of PYRUKYND® (mitapivat) as First Disease-Modifying Therapy for Hemolyt...
GlobeNewswire 2022-02-10 Agios to Webcast Conference Call of Fourth Quarter and Year End 2021 Financial Results on Feb. 24, 2...
GlobeNewswire 2022-01-18 Kymera Therapeutics Appoints Healthcare Industry Leader John Maraganore, Ph.D., to Board of Director...